TrialLeukemia2013
Azacitidine and donor lymphocyte infusions as first salvage therapy for relapse of AML or MDS after allogeneic stem cell transplantation.
T Schroeder et al.PubMed ↗Publisher ↗
No numbers read from the abstract.
117 papers cite itlatest 60 shown
this papertrialcites it